Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design - Wikidata - wikimedia - TriplyDB

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

http://www.wikidata.org/entity/Q28075274

about

Some vexations that challenge viral immunology Systems serology for evaluation of HIV vaccine trials.Vaccine candidate discovery for the next generation of malaria vaccines.Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies Applying proteomics to tick vaccine development: where are we?Fighting Neisseria meningitidis: past and current vaccination strategies.Mathematical modeling based on ordinary differential equations: A promising approach to vaccinology.Towards functional antibody-based vaccines to prevent pre-erythrocytic malaria infection.Nanoparticle orientationally displayed antigen epitopes improve neutralizing antibody level in a model of porcine circovirus type 2.Using homology modeling to interrogate binding affinity in neutralization of ricin toxin by a family of single domain antibodies.CryoEM Structure of an Influenza Virus Receptor-Binding Site Antibody-Antigen Interface.What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise.One vaccinology? Overcoming challenges in vaccine development.Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development.Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model.Extended low-resolution structure of a Leptospira antigen offers high bactericidal antibody accessibility amenable to vaccine design.EMA and EFSA Joint Scientific Opinion on measures to reduce the need to use antimicrobial agents in animal husbandry in the European Union, and the resulting impacts on food safety (RONAFA)Perspectives in allergen immunotherapy: 2017 and beyond.Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbp.Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is ("Isolate-Inactivate-Inject") Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview.An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus.Genome-wide identification of novel vaccine candidates for Plasmodium falciparum malaria using integrative bioinformatics approaches.Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.Computational Modeling of Hepatitis C Virus Envelope Glycoprotein Structure and Recognition.A qualitatively validated mathematical-computational model of the immune response to the yellow fever vaccine.Changing Priorities in Vaccinology: Antibiotic Resistance Moving to the Top.Towards conformational fidelity of a quaternary HIV-1 epitope: computational design and directed evolution of a minimal V1V2 antigen.The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen Bacterial Vaccine Antigen Discovery in the Reverse Vaccinology 2.0 Era: Progress and Challenges Targeting Difficult Protein-Protein Interactions with Plain and General Computational Approaches A Gene-Based Positive Selection Detection Approach to Identify Vaccine Candidates Using as a Test Case Protozoan Pathogen Beyond Hot Spots: Biases in Antibody Somatic Hypermutation and Implications for Vaccine Design When designing vaccines, consider the starting material: the human B cell repertoire

P2860

Q24672537-32EE35F1-D5CE-4395-8B96-AD359ECBA66C Q30238729-88D2DFBC-A719-4C6C-A8AA-97EF168D6E05 Q36413834-E4947E81-CD11-455C-8646-89553786A3D2 Q37621530-45F0A687-1D02-492B-819A-5191A4DF4221 Q38768895-121334DF-5D0E-48B4-9A91-41A070886792 Q38829564-BBB09A14-59A3-432C-8452-3423C1BC80E2 Q39062411-03373D77-3836-4EE2-8EDD-8F741A0A1785 Q39170404-7A872D90-AD81-4675-9752-12E613569725 Q40109161-FC72E4E4-1250-44CB-88EB-78BD29A64A11 Q40130441-184A7B8F-F61A-4637-B0A3-ABC17EFE2F91 Q40200645-072856E4-417A-4096-B20D-D419ED9D385F Q40346058-3408A7C7-E1F5-4509-AE8F-BCFAD419399D Q40470909-56630619-E311-4178-8463-037AB5ADA6F6 Q41936503-F27E7977-2C02-4D5C-8379-63C83934DB64 Q42377340-6DF774F6-0E0F-4BCF-9349-C3959CB537B4 Q47155273-FED1A45B-9965-4AE9-B3D2-02CE1E1E1201 Q47158624-D855B670-7AF6-425F-BFE8-157AF507A302 Q47700986-315B7C0D-D803-4884-85A2-04EBC2BF19AE Q48095992-34D08670-5B02-46E3-8F9A-9A6D956135C6 Q51416013-C7B3305D-4F04-4D89-9DC7-B7C1227E054C Q52317335-C93B387D-4F45-4CDA-926E-60F19AAD3FEB Q53056444-F23D1775-80E4-4CFD-AEB7-30E819601C3E Q54233532-C81E70F3-9FF4-4B50-BAAA-48AB0339D327 Q55003572-E70DA578-EC22-4C60-9FA3-4E15AB8BF64A Q55053671-A901305D-74FF-4C10-B04D-B213BC7F5B37 Q55340953-DF896BAC-DE81-42B4-8C5E-C78CD792522F Q55518743-21DA7D4B-B4E1-4390-A24E-5CE64E40CE53 Q57094341-55957B8F-9D47-4497-A495-1BC2B18651E5 Q57817461-C53001D5-539B-4980-A7FA-31FC63BBB29C Q58691534-2F3E5798-0F62-469B-B4C6-66DD4DCEC7B7 Q58735723-A13CE31A-AC19-44DC-A772-F62CBD83DEF2 Q58781552-97D89F1D-1C00-42D8-B69F-EDB1DE508E63 Q58804243-DE220EEF-E278-4B04-8CC2-838FB3B778FB

P2860

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

http://www.wikidata.org/entity/Q28075274

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

@ast

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

@en

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

@nl

type

label

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

@ast

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

@en

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

@nl

prefLabel

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

@ast

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

@en

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

@nl

P1433

Q28075274-CAF37049-2D3F-48FC-B271-063BB2A40FB4

P1476

Q28075274-22888A8F-A038-4415-8153-FAF4ACBBEFAB

P2093

Q28075274-0E53FAD3-3D5A-4EBC-A8D7-80B48BA1867B

Q28075274-2C38035C-98C3-472B-8A25-0D560DA42B70

Q28075274-A087A32C-B5CF-42CE-9738-98754B4C0D4B

Q28075274-A964FA74-E828-4E81-B04D-6F4F56C3F589

P2860

Q28075274-0285C68E-5607-405A-B867-15DD7170CD7E

Q28075274-0371EFE9-1AA6-42D5-B7D6-0F20AAA7E59F

Q28075274-044AA6A7-FF3C-4F83-99BD-091015B40608

Q28075274-0D45B3D7-FC01-446D-A90A-43538C4FAE06

Q28075274-0F42989D-5B33-4B27-B057-6DD633129C36

Q28075274-0FCA92DC-34DC-4047-9063-628302C5640C

Q28075274-10AE1D9F-5734-4229-81B7-C45BD7CA80C1

Q28075274-19E6A4C7-BB3D-4075-B93A-C540F456BE4E

Q28075274-1A34C22C-8FAC-42ED-99BE-5BD46433B5F0

Q28075274-1ABEFA61-2AC7-4B2B-9A61-AA68C904A89A

P304

Q28075274-F54DEDD4-613A-4D80-9DEC-6D35F804D75D

P31

Q28075274-9489199F-0910-4245-93E0-B671AD7B805C

Q28075274-BFCD5676-533E-4401-AE86-36ABF0D4F323

P3181

Q28075274-DC55CB07-0889-416A-8DDD-94AFAF6CD711

P356

Q28075274-3C81B56A-8200-4F97-A2C1-259EC7874B8D

P407

Q28075274-8EB25B69-99CB-4675-B473-10C6DA064155

P433

Q28075274-57367A47-A3C9-4AEB-AD0D-C98E651BD11B

P478

Q28075274-CC1F8D67-EBF4-4549-A881-A871D97A0DA5

P50

Q28075274-26BBA5AA-063B-4CA3-863C-B03DA309E4DE

P577

Q28075274-04668533-DB7D-4D37-8E55-ED36272C8969

P5875

Q28075274-8ECF66BC-8051-4018-92A6-C3868A4DFE94

P698

Q28075274-D3658163-32AB-42DF-8559-90716D915204

P921

Q28075274-B52A36EB-EAF1-457C-93B3-13B933121EE7

P932

Q28075274-A3202F50-7C88-45A5-82C4-1C3DB1579794

P3181

P356

P1433

Journal of Experimental Medicine

P1476

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

@en

P2093

Ennio De Gregorio

http://www.w3.org/2001/XMLSchema#string

Matthew J. Bottomley

http://www.w3.org/2001/XMLSchema#string

Oretta Finco

http://www.w3.org/2001/XMLSchema#string

Ugo D’Oro

http://www.w3.org/2001/XMLSchema#string

P2860

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

A highly conserved neutralizing epitope on group 2 influenza A viruses

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Antibody recognition of a highly conserved influenza virus epitope

Self-assembling protein nanoparticles in the design of vaccines

Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens

Antibody responses to envelope glycoproteins in HIV-1 infection

P304

469-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1230830

http://www.w3.org/2001/XMLSchema#string

P356

10.1084/JEM.20151960

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

213

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299476700

http://www.w3.org/2001/XMLSchema#string

P698

27022144

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

4821650

http://www.w3.org/2001/XMLSchema#string